December 2013 Editor’s Comment – OTC.NewDirections

DaveNDheaderAs the festive season fast approaches, several medicine agencies are reminding marketers of deadlines for certain marketing authorisation submissions. The European Medicines Agency has an imminent deadline for Type-IA variations (a change that has only a minimal effect, or no impact at all, on the quality, safety or efficacy of the medicinal product concerned), while medicines agencies in Belgium, Denmark and Latvia have also issued reminders about upcoming deadlines. For more details, see tomorrow’s edition of OTC.NewDirections.
Continue reading